Anondita Medicare Receives NSE In-Principle Approval For ₹109.782 Crore Rights Issue

NSE granted in-principle approval for Anondita Medicare’s proposed rights issue aggregating up to ₹109.78 crore. Issue terms remain undisclosed; completion requires further approvals and compliance. The substantial equity raise may fund expansion but introduces dilution and financing uncertainty.